These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma]. Tamura A; Oita T; Sakizono K; Nakajima T; Kasakura S Rinsho Byori; 1998 Feb; 46(2):158-62. PubMed ID: 9528340 [TBL] [Abstract][Full Text] [Related]
5. Serological markers of liver cancer. Yuen MF; Lai CL Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):91-9. PubMed ID: 15757806 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma. Cui R; Wang B; Ding H; Shen H; Li Y; Chen X Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656 [TBL] [Abstract][Full Text] [Related]
7. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Tateishi R; Shiina S; Yoshida H; Teratani T; Obi S; Yamashiki N; Yoshida H; Akamatsu M; Kawabe T; Omata M Hepatology; 2006 Dec; 44(6):1518-27. PubMed ID: 17133456 [TBL] [Abstract][Full Text] [Related]
8. [Optimal cut-off value of PIVKA-II for diagnosis of hepatocellular carcinoma--using ROC curve]. Kim MJ; Bae KW; Seo PJ; Jeong IK; Kim JH; Lee BH; Bang KT; Kim DW; Song IH Korean J Hepatol; 2006 Sep; 12(3):404-11. PubMed ID: 16998292 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956 [TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of PIVKA-II as a marker of hepatocellular carcinoma]. Arima K; Kodama T; Suga M; Sakamoto H; Ohe Y; Yachi A Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3049-52. PubMed ID: 2476968 [TBL] [Abstract][Full Text] [Related]
11. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study. Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197 [TBL] [Abstract][Full Text] [Related]
12. Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma. Tanaka Y; Kashiwagi T; Tsutsumi H; Nagasawa M; Toyama T; Ozaki S; Naito M; Ishibashi K; Azuma M Hepatogastroenterology; 1999; 46(28):2464-8. PubMed ID: 10522021 [TBL] [Abstract][Full Text] [Related]
13. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma. Tada T; Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kitabatake S; Kuzuya T; Nonogaki K; Shimizu J; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J; Satomura S Liver Int; 2005 Aug; 25(4):848-53. PubMed ID: 15998436 [TBL] [Abstract][Full Text] [Related]
14. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Sterling RK; Jeffers L; Gordon F; Venook AP; Reddy KR; Satomura S; Kanke F; Schwartz ME; Sherman M Clin Gastroenterol Hepatol; 2009 Jan; 7(1):104-13. PubMed ID: 18849011 [TBL] [Abstract][Full Text] [Related]
15. [Clinical usefulness of plasma PIVKA-II assay and its limitations in patients with hepatocellular carcinoma]. Fujiyama S; Morishita T; Shibata J; Sato T Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1129-38. PubMed ID: 2471453 [TBL] [Abstract][Full Text] [Related]
16. [Tumor markers for hepatocellular carcinoma]. Fujiyama S; Tanaka M; Maeda S; Ashihara H; Hirata R Gan To Kagaku Ryoho; 2001 May; 28(5):723-32. PubMed ID: 11383225 [TBL] [Abstract][Full Text] [Related]
17. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma. Fujioka M; Nakashima Y; Nakashima O; Kojiro M Hepatology; 2001 Dec; 34(6):1128-34. PubMed ID: 11732002 [TBL] [Abstract][Full Text] [Related]
18. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630 [TBL] [Abstract][Full Text] [Related]
19. [The studies on early warning of Lens culinaris-reactive alpha-Fetoprotein (AFP-L3) detecting in primary hepatocellular carcinoma]. Li YL; Ma HB; Guo JX; Shi JB; Xu J; Liu AX; Yang LH; Li BA; Mao YL Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):336-8. PubMed ID: 19469167 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma. Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]